Intentional delayed delivery in twin pregnancy. Two additional cases and literature review

European Journal of Obstetrics, Gynecology, and Reproductive Biology
P AbboudE Janky

Abstract

We report two cases of retention of the second twin after delivery of the first one. Both pregnancies were bichorionic, biamniotic. In both cases the first twin was delivered during the second trimester. Tocolysis and antibiotics were used. The two pregnancies had a different outcome. For the first patient with a cerclage, the interval delivery was 67 days, allowing a gestational age of 28 weeks and a weight of 1070 g. The child is now 4 years old and has a normal development. In the second case, the second twin was delivered at 20 1/2 weeks, 8 days after the first, and died shortly after birth. Reviewing the literature, 34 twin pregnancies are reported with intentional delay delivery and 27 infants survived out of 68 fetuses. Cerclage does not seem to be essential for success. Prophylactic antibiotics and tocolysis are admitted. The main problem is infection which defines the prognosis.

References

Mar 1, 1992·Obstetrical & Gynecological Survey·P P PoeschmannH W Bruinse
Dec 1, 1991·British Journal of Obstetrics and Gynaecology·M G LongH Gamsu
Nov 26, 1991·European Journal of Obstetrics, Gynecology, and Reproductive Biology·L M JensenT Weber
Oct 1, 1989·American Journal of Obstetrics and Gynecology·W FeichtingerH Fröhlich
Aug 1, 1984·European Journal of Obstetrics, Gynecology, and Reproductive Biology·I H Omsjø, R Alsos
Jul 1, 1983·British Journal of Obstetrics and Gynaecology·J WoolfsonA Bates
Nov 1, 1995·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M W de JongJ van Eijck

❮ Previous
Next ❯

Citations

Oct 23, 2009·Archives of Gynecology and Obstetrics·Mehmet Ali YucePetek Balkanli Kaplan
Jun 24, 2003·European Journal of Obstetrics, Gynecology, and Reproductive Biology·S FayadJ Y Gillet
Sep 23, 2000·European Journal of Obstetrics, Gynecology, and Reproductive Biology·B Bollen, M Padwick
Jun 28, 2005·Fetal Diagnosis and Therapy·Stéphane CristinelliPatricia Monnier-Barbarino
Jan 3, 2014·Case Reports in Obstetrics and Gynecology·Monika LachowskaBarbara Królak-Olejnik
Sep 21, 2006·The Journal of Obstetrics and Gynaecology Research·Willibald ZeckUwe Lang
Mar 16, 2013·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Ismail Temur
Nov 14, 2007·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·R BaggaV Suri
Nov 30, 2006·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·A BhideB Thilaganathan
Dec 5, 2017·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Mohamed FarghaliKhaled Abdelrazek
Mar 31, 2006·Journal of the Chinese Medical Association : JCMA·Sheng-Po KaoDah-Ching Ding
May 11, 1999·Obstetrical & Gynecological Survey·J S Platt, C Rosa
Nov 5, 2014·Journal of Obstetrics and Gynaecology of India·Pablo Padilla-IserteAlfredo Perales-Marín

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.